Key result
This review discusses the evidence base, patient selection, and technological advances for device therapy in the primary and secondary prevention of sudden arrhythmic death.
This review summarizes the evidence base, patient selection, and technological advances for device therapy in managing cardiac tachyarrhythmias.
Offers guidance on device selection for sudden death prevention; leaves open optimal use of new technologies pending further trials.
Implantation of devices that can terminate cardiac arrhythmias has increased rapidly over recent years. This article looks at the evidence base for using such devices in the primary and secondary prevention of sudden arrhythmic death, discusses who should have a device and examines the issues surrounding implantation. Recent advances in technology and the future direction of therapy are also reviewed.
No takes yet. Share an insight, caveat, or question.
Shetty et al. (2010) conducted a review in Cardiac tachyarrhythmias and sudden arrhythmic death. Device therapy was evaluated. This review discusses the evidence base, patient selection, and technological advances for device therapy in the primary and secondary prevention of sudden arrhythmic death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: